Analysts Set Okta, Inc. (NASDAQ:OKTA) PT at $172.92
Shares of Okta, Inc. (NASDAQ:OKTA – Get Free Report) have received a consensus rating of “Moderate Buy” from the forty-three brokerages that are covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold rating, thirty-two have issued a buy rating and one has assigned a strong buy rating to […]
Analysts Set Tilray Brands, Inc. (NASDAQ:TLRY) PT at $8.00
Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) has been given a consensus recommendation of “Hold” by the seven brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation, two have assigned a buy recommendation and one […]
Analysts Set Foghorn Therapeutics Inc. (NASDAQ:FHTX) PT at $11.43
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) has been given an average rating of “Moderate Buy” by the eight analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a buy recommendation and one has given a strong buy recommendation […]
Analysts Set Cerebras Systems Inc. (NASDAQ:CBRS) PT at $299.90
Shares of Cerebras Systems Inc. (NASDAQ:CBRS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, nine have assigned a buy recommendation and one […]
last updated on 9 Sep 08:08